Neupro: Medgend

Search instead for neurons

Neupro FDA Approved Drugs

NEUPRO [Rotigotine^{C₁₉H₂₅NOS}]

1mg/24hr (transdermal film, extended release)

2mg/24hr (transdermal film, extended release)

3mg/24hr (transdermal film, extended release)

4mg/24hr (transdermal film, extended release)

6mg/24hr (transdermal film, extended release)

8mg/24hr (transdermal film, extended release)

Ucb Inc^{Apr 2, 2012}

A method for the treatment of a patient suffering from a disease treatable with rotigotine, comprising applying the claimed transdermal delivery system (tds) to the skin of the patient.
Treatment of restless legs syndrome by application of claimed transdermal delivery system.
Treatment of signs and symptoms of parkinson's disease by application of claimed transdermal system.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.